What we do
COVID-19 in the Netherlands
RIVMNational Institute for Public Health and the Environment advises the Dutch government on how to control the coronavirus as effectively as possible, monitors the COVID-19 outbreak and conducts research into SARS-CoV-2. RIVM is coordinating the implementation of the COVID-19 vaccinations in the Netherlands. Our institute is responsible for coordinating the storage and distribution of COVID-19 vaccines in the Netherlands (including the islands of Aruba, Bonaire, St Eustatius, Saba, Curaçao and St Maarten).
We provide weekly updates and data on COVID-19 in the Netherlands. In addition to our general COVID-19 weekly epidemiological update, we also publish a COVID-19 weekly update for the CAS and BES islands: the islands of Curaçao, Aruba and Sint Maarten and the special municipalities Bonaire, Sint Eustatius and Saba.
COVID-19 vaccination very effective: major drop in positive tests, hospital admissions and deaths among older people
People over 75 years old living at home are 82% protected against testing positive for COVID-19 from three weeks after the second vaccination.
Launch of the European project RISK-HUNT3R
The new Horizon 2020 project RISK-HUNT3R: RISK assessment of chemicals integrating HUman centric Next generation Testing strategies promoting the 3Rs was launched on 1 June.
Effects of COVID-19 vaccination becoming increasingly visible
In the past calendar week, there were 43% fewer hospital admissions of patients with COVID-19 compared to the week before.
At least 87% of people over 65 vaccinated at least once: high turnout, few regional differences
Four months after the launch of the vaccination campaign, at least 87% of people over 65 in the Netherlands have been vaccinated against COVID-19 at least once.
Quality assessment of SARS-CoV-2 antigen test diagnostics: good performance at public test sites in the Netherlands
In their role as WHO reference laboratories, RIVM and Erasmus UMC conducted a
Long-term symptoms more common after Lyme disease
More than a quarter of people with Lyme disease continue to have long-term symptoms that lead to limitations in daily life even after treatment.